Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants (DOACs) and a recent intake within the last 48 hours in US and European guidelines. However, three observational studies now suggest safety of thrombolysis in patients with recent intake of DOACs, and thus support previous experimental data. In this perspective, the current evidence and practical consequences are discussed.
CITATION STYLE
Purrucker, J. C., Meinel, T. R., Wilson, D., Xian, Y., Wu, T. Y., & Seiffge, D. J. (2024). Thrombolysis for ischaemic stroke despite direct oral anticoagulation. Stroke and Vascular Neurology. BMJ Publishing Group. https://doi.org/10.1136/svn-2023-002727
Mendeley helps you to discover research relevant for your work.